Advanced Malignant Neoplasm
45
4
14
15
Key Insights
Highlights
Success Rate
68% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
15.6%
7 terminated out of 45 trials
68.2%
-18.4% vs benchmark
2%
1 trials in Phase 3/4
47%
7 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (45)
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
RCT of QPS vs General Information Sheet
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
Financial Distress in Advanced Cancer Patients
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
Cordotomy in Reducing Pain in Patients With Advanced Cancer
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies